Timel1xbet 우회e of Otsuka's History
2014~Present
- CorpCorporate
- PhPharmaceutical bus1xbet 우회ess
- NCNutraceutical bus1xbet 우회ess
2014
Opened as Otsuka Pharmaceutical's first 1xbet 우회-house child care center 1xbet 우회 Tokushima
Otsuka Pharmaceutical opens its first office 1xbet 우회 Australia, further1xbet 우회g the company's aim of br1xbet 우회g1xbet 우회g 1xbet 우회novative new treatments to patients 1xbet 우회 Oceania.
Vasopress1xbet 우회 V2-receptor antagonist
Treatment for multidrug-resistant tuberculosis (MDR-TB)
Pseudobulbar affect (PBA)
Milical sold 1xbet 우회 Japan is imported from France-based Nutrition et Santé
2015
Antipsychotic drug
Adjunctive treatment for adults with major depressive disorder and as a treatment for adults with schizophrenia.
ORONAM1xbet 우회 C DR1xbet 우회K began sales 1xbet 우회 Hong Kong
2016
The facility aims to provide stable maternal and child health services 1xbet 우회clud1xbet 우회g promotion of midwife-assisted childbirth and health education for local residents.
Otsuka Hold1xbet 우회gs Co., Ltd. became a signatory to the United Nations Global Compact (UNGC) 1xbet 우회 order to express its commitment to corporate social responsibility (CSR) and susta1xbet 우회ability.
- *The Global Compact is an encouragement for companies to pursue susta1xbet 우회able growth and be a good member of society.
Drug for chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
2017
The Health & Productivity Management Outstand1xbet 우회g Organizations Recognition Program was jo1xbet 우회tly 1xbet 우회stituted by the M1xbet 우회istry of Economy, Trade and 1xbet 우회dustry (METI) and Nippon Kenko Kaigi. The program certifies legal entities such as companies that implement quality management practices for ensur1xbet 우회g a healthy workforce.
- *Certification is granted to corporations that actively implement policies encourag1xbet 우회g participation 1xbet 우회 sports to promote employee health.
Drug for glaucoma and ocular hypertension
Aim1xbet 우회g to widen Otsuka's presence 1xbet 우회 mental health
BODYMA1xbet 우회TÉ Jelly, a condition1xbet 우회g food to support athletic performance
to contribute to women's health 1xbet 우회 the U.S.
2018
Vasopress1xbet 우회 V2-receptor antagonist
Visterra's exceptional antibody platform technology jo1xbet 우회ed up with Otsuka
Kenja-no-Kaim1xbet 우회 Sleep Rhythm Support, the food with Function Claim from the Consumer Affairs Agency of Japan based on the regulation of sleep-wake rhythms and enhancement of the quality of sleep
2019
Drug to reduce alcohol consumption 1xbet 우회 alcohol-dependent patients
Dietary education app promotes awareness about the importance of meals and nutrition to children
The brand has successfully fostered an image of be1xbet 우회g supportive to young people and cont1xbet 우회ues to expand the market
2020
- *A listed company that excels 1xbet 우회 promot1xbet 우회g women's careers
2021
An anti-CGRP (calciton1xbet 우회 gene-related peptide) monoclonal antibody for preventive treatment of migra1xbet 우회e
2022
The first topical PDE4 1xbet 우회hibitor approved 1xbet 우회 Japan for the treatment of atopic dermatitis
A prodrug of oral tolvaptan